NYSE - Delayed Quote
USD
Merck & Co., Inc. (MRK)
150.33
-2.01
(-1.32%)
At close: September 4 at 4:03:59 PM EDT
152.00
+1.67
(+1.11%)
After hours: September 4 at 7:58:53 PM EDT
Trade MRK on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutMerck (MRK) is experiencing notable developments, particularly with its recent Phase 3 success in personalized mRNA melanoma therapy alongside Keytruda. Despite a dip in the broader market, Merck's stock has seen substantial growth over the past year, driven by strong pipeline prospects and recent trial results.
